OPKO Health ROE 2010-2024 | OPK
Current and historical return on equity (ROE) values for OPKO Health (OPK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| OPKO Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $-0.13B | $1.40B | -9.78% |
| 2024-06-30 | $-0.24B | $1.40B | -17.66% |
| 2024-03-31 | $-0.25B | $1.25B | -17.93% |
| 2023-12-31 | $-0.19B | $1.39B | -12.70% |
| 2023-09-30 | $-0.21B | $1.45B | -13.59% |
| 2023-06-30 | $-0.21B | $1.54B | -13.32% |
| 2023-03-31 | $-0.29B | $1.55B | -18.01% |
| 2022-12-31 | $-0.33B | $1.56B | -20.11% |
| 2022-09-30 | $-0.32B | $1.63B | -19.07% |
| 2022-06-30 | $-0.20B | $1.72B | -11.91% |
| 2022-03-31 | $-0.12B | $1.62B | -6.81% |
| 2021-12-31 | $-0.03B | $1.69B | -1.74% |
| 2021-09-30 | $0.08B | $1.77B | 4.42% |
| 2021-06-30 | $0.07B | $1.74B | 4.22% |
| 2021-03-31 | $0.12B | $1.70B | 7.35% |
| 2020-12-31 | $0.03B | $1.67B | 1.93% |
| 2020-09-30 | $-0.11B | $1.62B | -7.09% |
| 2020-06-30 | $-0.20B | $1.59B | -12.45% |
| 2020-03-31 | $-0.29B | $1.55B | -17.99% |
| 2019-12-31 | $-0.32B | $1.62B | -18.72% |
| 2019-09-30 | $-0.28B | $1.64B | -16.16% |
| 2019-06-30 | $-0.25B | $1.71B | -13.90% |
| 2019-03-31 | $-0.19B | $1.76B | -10.68% |
| 2018-12-31 | $-0.15B | $1.79B | -8.48% |
| 2018-09-30 | $-0.30B | $1.79B | -16.24% |
| 2018-06-30 | $-0.30B | $1.81B | -16.02% |
| 2018-03-31 | $-0.31B | $1.82B | -15.97% |
| 2017-12-31 | $-0.31B | $1.84B | -15.02% |
| 2017-09-30 | $-0.13B | $2.09B | -5.96% |
| 2017-06-30 | $-0.10B | $2.11B | -4.95% |
| 2017-03-31 | $-0.07B | $2.11B | -3.41% |
| 2016-12-31 | $-0.05B | $2.09B | -2.34% |
| 2016-09-30 | $-0.01B | $2.11B | -0.44% |
| 2016-06-30 | $0.13B | $2.02B | 6.73% |
| 2016-03-31 | $0.08B | $2.00B | 4.43% |
| 2015-12-31 | $-0.03B | $1.98B | -2.15% |
| 2015-09-30 | $-0.09B | $1.97B | -7.65% |
| 2015-06-30 | $-0.26B | $0.83B | -31.16% |
| 2015-03-31 | $-0.24B | $0.81B | -28.30% |
| 2014-12-31 | $-0.17B | $0.84B | -19.84% |
| 2014-09-30 | $-0.14B | $0.89B | -15.53% |
| 2014-06-30 | $-0.15B | $0.91B | -16.87% |
| 2014-03-31 | $-0.13B | $0.83B | -17.34% |
| 2013-12-31 | $-0.12B | $0.87B | -19.38% |
| 2013-09-30 | $-0.10B | $0.87B | -23.59% |
| 2013-06-30 | $-0.05B | $0.31B | -20.48% |
| 2013-03-31 | $-0.06B | $0.32B | -28.61% |
| 2012-12-31 | $-0.03B | $0.18B | -19.62% |
| 2012-09-30 | $-0.01B | $0.15B | -7.82% |
| 2012-06-30 | $-0.01B | $0.15B | -7.72% |
| 2012-03-31 | $-0.01B | $0.16B | -4.54% |
| 2011-12-31 | $-0.00B | $0.16B | -2.41% |
| 2011-09-30 | $-0.02B | $0.10B | -24.44% |
| 2011-06-30 | $-0.02B | $0.11B | -30.22% |
| 2011-03-31 | $-0.02B | $0.12B | -40.55% |
| 2010-12-31 | $-0.02B | $0.02B | -56.38% |
| 2010-09-30 | $-0.03B | $0.02B | -75.95% |
| 2010-06-30 | $-0.03B | $0.05B | -63.37% |
| 2010-03-31 | $-0.03B | $0.06B | -64.92% |
| 2009-12-31 | $-0.04B | $0.03B | -110.24% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.072B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $197.634B | 24.11 |
| Intuitive Surgical (ISRG) | United States | $186.606B | 97.56 |
| Edwards Lifesciences (EW) | United States | $43.604B | 27.69 |
| Alcon (ALC) | Switzerland | $41.521B | 27.78 |
| IQVIA Holdings (IQV) | United States | $34.761B | 19.15 |
| IDEXX Laboratories (IDXX) | United States | $33.493B | 39.44 |
| DexCom (DXCM) | United States | $29.615B | 44.60 |
| Waters (WAT) | United States | $21.413B | 31.66 |
| STERIS (STE) | Ireland | $20.170B | 23.22 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.359B | 0.00 |
| Hologic (HOLX) | United States | $16.058B | 17.34 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.192B | 13.54 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 36.77 |
| Globus Medical (GMED) | United States | $11.158B | 28.25 |
| Penumbra (PEN) | United States | $9.346B | 91.55 |
| Masimo (MASI) | United States | $9.102B | 44.04 |
| Teleflex (TFX) | United States | $8.118B | 12.95 |
| Glaukos (GKOS) | United States | $7.925B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.457B | 25.26 |
| PROCEPT BioRobotics (PRCT) | United States | $4.215B | 0.00 |
| Inari Medical (NARI) | United States | $3.185B | 0.00 |
| Veracyte (VCYT) | United States | $3.028B | 90.86 |
| Nihon Kohden (NHNKY) | Japan | $2.590B | 19.67 |
| LivaNova (LIVN) | United Kingdom | $2.579B | 14.89 |
| Tandem Diabetes Care (TNDM) | United States | $2.185B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.096B | 18.84 |
| TransMedics (TMDX) | United States | $2.031B | 64.39 |
| Integra LifeSciences Holdings (IART) | United States | $1.675B | 8.75 |
| RxSight (RXST) | United States | $1.539B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.255B | 0.00 |
| Artivion (AORT) | United States | $1.173B | 77.69 |
| Pulse Biosciences (PLSE) | United States | $1.094B | 0.00 |
| Paragon 28 (FNA) | United States | $0.820B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.760B | 12.92 |
| Mesa Laboratories (MLAB) | United States | $0.714B | 16.83 |
| IRadimed (IRMD) | United States | $0.676B | 36.54 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.657B | 0.00 |
| AxoGen (AXGN) | United States | $0.654B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.568B | 29.92 |
| SiBone (SIBN) | United States | $0.547B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.430B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.407B | 22.01 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.357B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.349B | 0.00 |
| NeuroPace (NPCE) | United States | $0.333B | 0.00 |
| CVRx (CVRX) | United States | $0.284B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.219B | 0.00 |
| Inogen (INGN) | United States | $0.198B | 0.00 |
| Accuray (ARAY) | United States | $0.180B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.171B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.170B | 0.00 |
| Nevro (NVRO) | United States | $0.135B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.123B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.118B | 12.65 |
| Spectral Diagnostics (EDTXF) | Canada | $0.094B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.068B | 0.00 |
| 908 Devices (MASS) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.066B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.058B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Neuronetics (STIM) | United States | $0.039B | 0.00 |
| Envoy Medical (COCH) | United States | $0.037B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.031B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.008B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |